elacestrant
Showing 1 - 16 of 16
Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago
Not yet recruiting
- Estrogen-receptor-positive Breast Cancer
- +3 more
- elacestrant, palbociclib, abemaciclib, ribociclib
-
Chicago, IllinoisNorthwestern University
Sep 25, 2023
Hepatic Impairment Trial (Elacestrant diHCl)
Not yet recruiting
- Hepatic Impairment
- Elacestrant dihydrochloride
- (no location specified)
Nov 6, 2023
Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)
Not yet recruiting
- Breast Cancer
- +3 more
- Elacestrant
- Triptorelin
- (no location specified)
Aug 4, 2023
Metastatic Breast Cancer Trial (Elacestrant)
Not yet recruiting
- Metastatic Breast Cancer
- Elacestrant
- (no location specified)
Oct 24, 2022
Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)
Completed
- Breast Cancer
- Hormone Receptor Positive Breast Carcinoma
- Elacestrant
-
Badalona, Barcelona, Spain
- +3 more
Oct 25, 2022
ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)
Not yet recruiting
- ER-positive Breast Cancer
- +3 more
- Elacestrant
- +4 more
- (no location specified)
Aug 22, 2022
Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Elacestrant
- +4 more
- (no location specified)
Sep 28, 2022
Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)
Recruiting
- Breast Neoplasms
- +7 more
- Elacestrant
- Abemaciclib
-
Canton, OhioGabrail Cancer Center
Jan 24, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Elacestrant Dihydrochloride
-
Orange City, Florida
- +27 more
Jul 19, 2023
Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)
Completed
- Advanced ER+, HER2-Negative Breast Cancer
- Elacestrant
-
Waltham, MassachusettsRadius Pharmaceuticals, Inc.
Aug 16, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
Vasomotor Symptoms, Hot Flashes Trial in Kalamazoo (RAD1901, Placebo)
Terminated
- Vasomotor Symptoms
- Hot Flashes
- RAD1901
- Placebo
-
Kalamazoo, MichiganWomen's Health Care Specialists P.C. - Beyer Research
Mar 12, 2019